2008 was a fairly tumultuous one in the protection industry in terms of product innovation. But which do you think will be the most influential in the long-run?
That's not a bad overall for an entire year, particularly in this industry, and it's easy/lazy for us to sit back and amiably wish that 2009 will see more of the same. But the real question, and the most interesting protection-related topic, is which of these will still be leaving their marks on the protection sector in three, five, ten and twenty year's time?
Rather than try to answer this question ourselves, over the next few months we're going to pitch it to the adviser community, starting with an upcoming feature outlining what each of these products brought to the table last year.
Then, the important bit.
We're going to conduct a poll on this website and we'd like you to tell us which of these products you think is going, in the long run, to be the most influential of 2008.
The polls open next month. We hope to see you here.
The news that the ABI and British Medical Association (BMA) agreement on GP report (GPR) fees has broken down will usher in a period of uncertainty.
Lack of innovation investment in the UK insurance market has been highlighted by recognition of RGA's work in the US.
Protection business in 2012 and 2013 will be affected by events this year and some fundamental changes to the way customers policies are priced into the next. Richard Verdin explains.
Employee assistance programmes are in the spotlight due to a schizophrenic approach by government. But as Sue Weir points out, they are backed by solid research.
How will people buy insurance in future? Greg Becker visits the US for developments in online distribution.